During the past decade, Wisconsin Institutes for Medical Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Wisconsin Institutes for Medical Research" are "Advanced Solid Tumor" (1 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Extensive-Stage Small Cell Lung Cancer" (1 trials) and "Gynecologic Cancer" (1 trials). Many other conditions were trialed in "Wisconsin Institutes for Medical Research" in a lesser frequency.

Most popular intervention types in "Wisconsin Institutes for Medical Research" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Combination Therapy: PY314 + Pembrolizumab" (1 trials), "Etoposide" (1 trials), "Ipilimumab" (1 trials) and "Non-contrast MRI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wisconsin Institutes for Medical Research" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Wisconsin Institutes for Medical Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Wisconsin Institutes for Medical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wisconsin Institutes for Medical Research, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".